MedTrace Logo

DD2-Coronary Plaque Morphology and Plaque Progression

NCT03022344 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2018-05-08

No results posted yet for this study

Summary

However, there is only very sparse information regarding the atherosclerotic burden and cardiovascular biomarkers in the early stages of type-2 diabetes, as the vast majority of studies have concerned diabetes populations with more than 5 years average diabetes age or high-risk subgroups, who at inclusion already had atherosclerotic disease manifestations.

Consequently, this study aims on evaluating the occurrence of early-stage subclinical atherosclerosis in newly diagnosed type-2 diabetes with special emphasis on coronary plaque characteristics by modern imaging techniques. These findings will be compared to the functional status of various peripheral arterial segments and biomarkers in the cross-sectional part of this study. The 5-year follow-up study intends to describe relationships between these selected measures for general atherosclerotic involvement and the progression of the coronary atherosclerotic burden by contemporary techniques.

Conditions

Interventions

RADIATION

Cardiac CT

Sponsors & Collaborators

  • The Danish Diabetes Academy supported by the Novo Nordisk Foundation

    collaborator UNKNOWN

  • University of Southern Denmark

    collaborator OTHER

  • Department of Regional Health Research - Center Southwest

    collaborator UNKNOWN

  • Edith and Vagn Hedegaard Jensens Foundation

    collaborator UNKNOWN

  • Karola Jørgensens Foundation and Foundation for Cardiology in Southwest Denmark.

    collaborator UNKNOWN

  • Esbjerg Hospital - University Hospital of Southern Denmark

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2021-06-30
Completion
2021-10-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03022344 on ClinicalTrials.gov